COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 2969: Articles 29681-29690  | Next

An SEIR Model for Assessment of Current COVID-19 Pandemic Situation in the UK
SUN, P., Li, K.
10.1101/2020.04.12.20062588 — Posted: 2020-04-17
Analysis of the SARS-Cov-2 epidemic in Lombardy (Italy) in its early phase. Are we going in the right direction?
Riccio, A.
10.1101/2020.04.12.20062919 — Posted: 2020-04-17
COVID-19 pandemic: A Hill type mathematical model predicts the US death number and the reopening date
Aboelkassem, Y.
10.1101/2020.04.12.20062893 — Posted: 2020-04-17
Immediate and Near Future Prediction of COVID-19 Patients in the U.S. Population Aged 65+ With the Prior Medical Conditions of Hypertension, Cardiovascular and Lung Diseases: Methods, Models and Acute Care Estimates
S.R. Srinivasa Rao, A., Miller, D. D., Berman, A. E., Hess, D. C., Krantz, S. G.
10.1101/2020.04.12.20062166 — Posted: 2020-04-17
Ad-hoc Assembly of Lean Extracorporeal Membrane Oxygenation Systems for COVID-19
Hunziker, P., Zenklusen, U.
10.1101/2020.04.12.20061929 — Posted: 2020-04-17
Distinct early IgA profile may determine severity of COVID-19 symptoms: an immunological case series
Dahlke, C., Heidepriem, J., Kobbe, R., Santer, R., Koch, T., Fathi, A., Ly, M. L., Schmiedel, S., Seeberger, P. H., ID-UKE COVID-19 study group, , Addo, M. M., Loeffler, F. F.
10.1101/2020.04.14.20059733 — Posted: 2020-04-17 Discussion: Offsite
A High Through-put Assay for Circulating Antibodies Directed against the S Protein of Severe Acute Respiratory Syndrome Corona virus 2
Weiss, S., Klingler, J., Hioe, C., Amanat, F., Baine, I., Kojic, E. M., Stoever, J., Liu, S., Jurczyszak, D., Bermudez-Gonzalez, M., Simon, V., Krammer, F., Zolla-Pazner, S.
10.1101/2020.04.14.20059501 — Posted: 2020-04-17
An experimental trial of recombinant human interferon alpha nasal drops to prevent coronavirus disease 2019 in medical staff in an epidemic area
Meng, Z., Wang, T., Li, C., Chen, X., Li, L., Qin, X., Li, H., Luo, J.
10.1101/2020.04.11.20061473 — Posted: 2020-04-17 Discussion: Onsite
Lopinavir/ritonavir for the treatment of COVID-19: A living systematic review protocol
Verdugo-Paiva, F., Izcovich, A., Ragusa, M., Rada, G., COVID-19 L-OVE Working Group
10.1101/2020.04.11.20062109 — Posted: 2020-04-17
The Estimated Time-Varying Reproduction Numbers during the Ongoing Epidemic of the Coronavirus Disease 2019 (COVID-19) in China
Hu, F.-C., Wen, F.-Y.
10.1101/2020.04.11.20061838 — Posted: 2020-04-17 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).